{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:02:42Z","timestamp":1791237762155,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"R\u00e9seau International des Instituts Pasteur","award":["ACIP A13_2011"],"award-info":[{"award-number":["ACIP A13_2011"]}]},{"name":"FEDER European Union","award":["FED-1-1.4 32932"],"award-info":[{"award-number":["FED-1-1.4 32932"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12866-016-0749-9","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T16:23:27Z","timestamp":1466871807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe"],"prefix":"10.1186","volume":"16","author":[{"name":"The Laboratory working group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Guyomard-Rabenirina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Malespine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Ducat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syndia","family":"Sadikalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Falord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Harrois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dozois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Breurec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Talarmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,24]]},"reference":[{"key":"749_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"749_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.euus.2004.08.003","volume":"2","author":"MC Bishop","year":"2004","unstructured":"Bishop MC. Uncomplicated Urinary Tract Infection. EAU Updat Ser. 2004;2:143\u201350.","journal-title":"EAU Updat Ser"},{"key":"749_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","volume":"66","author":"BA Rogers","year":"2011","unstructured":"Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66:1\u201314.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkg280","volume":"52","author":"G Kahlmeter","year":"2003","unstructured":"Kahlmeter G, Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother. 2003;52:128\u201331.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","volume":"39","author":"G Kahlmeter","year":"2012","unstructured":"Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: The ECO SENS study revisited. Int J Antimicrob Agents. 2012;39:45\u201351.","journal-title":"Int J Antimicrob Agents"},{"key":"749_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3855\/jidc.34","volume":"3","author":"R Bercion","year":"2009","unstructured":"Bercion R, Mossoro-Kpinde D, Manirakiza A, Le Faou A. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African Republic. J Infect Dev Ctries. 2009;3:187\u201390.","journal-title":"J Infect Dev Ctries"},{"key":"749_CR7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3855\/jidc.362","volume":"1","author":"JM Sire","year":"2007","unstructured":"Sire JM, et al. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J Infect Dev Ctries. 2007;1:263\u20138.","journal-title":"J Infect Dev Ctries"},{"key":"749_CR8","unstructured":"SPILF 2014 Mise au point Diagnostic et Antibioth\u00e9rapie des infections Urinaires Bact\u00e9riennes Communautaires de l\u2019Adulte. Splif. 2014. http:\/\/www.infectiologie.com\/UserFiles\/File\/medias\/Recos\/2014-infections_urinaires-long.pdf ."},{"key":"749_CR9","volume-title":"Comite de l\u2019Antibiogramme de la Societe Francaise de Microbiologie: Recommandations","author":"CA-SFM","year":"2013","unstructured":"CA-SFM. Comite de l\u2019Antibiogramme de la Societe Francaise de Microbiologie: Recommandations. 2013. Edition de janvier 2013."},{"key":"749_CR10","first-page":"161","volume":"209","author":"M Saladin","year":"2002","unstructured":"Saladin M, et al. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett. 2002;209:161\u20138.","journal-title":"FEMS Microbiol Lett"},{"key":"749_CR11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-1097(97)00196-1","volume":"152","author":"G Arlet","year":"1997","unstructured":"Arlet G. Rouveau, M. & Philippon, a. Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase. FEMS Microbiol Lett. 1997;152:163\u20137.","journal-title":"FEMS Microbiol Lett"},{"key":"749_CR12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/AAC.48.4.1249-1255.2004","volume":"48","author":"C Eckert","year":"2004","unstructured":"Eckert C, et al. Dissemination of CTX-M-Type \u03b2 -Lactamases among Clinical Isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother. 2004;48:1249\u201355.","journal-title":"Antimicrob Agents Chemother"},{"key":"749_CR13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jac\/47.6.773","volume":"47","author":"K Hryniewicz","year":"2001","unstructured":"Hryniewicz K, et al. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother. 2001;47:773\u201380.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.purol.2013.03.009","volume":"23","author":"F Bruy\u00e8re","year":"2013","unstructured":"Bruy\u00e8re F, Vidoni M, P\u00e9an Y, Ruimy JA, Elfassi R. Analyse microbiologique de plus de 600 infections urinaires f\u00e9briles prises en charge dans un r\u00e9seau de soin. Progr\u00e8s en Urol. 2013;23:890\u20138.","journal-title":"Progr\u00e8s en Urol"},{"key":"749_CR15","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/jac\/dkv043","volume":"70","author":"D Ironmonger","year":"2015","unstructured":"Ironmonger D, et al. Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4\u00a0years. J Antimicrob Chemother. 2015;70:1744\u201350.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s15010-007-6180-2","volume":"35","author":"KB Laupland","year":"2007","unstructured":"Laupland KB, Ross T, Pitout JDD, Church DL, Gregson DB. Community-onset urinary tract infections: A population-based assessment. Infection. 2007;35:150\u20133.","journal-title":"Infection"},{"key":"749_CR17","doi-asserted-by":"crossref","first-page":"349597","DOI":"10.1100\/2012\/349597","volume":"2012","author":"E Magliano","year":"2012","unstructured":"Magliano E, et al. Gender and age-dependent etiology of community-acquired urinary tract infections. ScientificWorldJournal. 2012;2012:349597.","journal-title":"ScientificWorldJournal"},{"key":"749_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jmii.2012.05.012","volume":"46","author":"S Maraki","year":"2013","unstructured":"Maraki S, Mantadakis E, Michailidis L, Samonis G. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005\u20132010. J Microbiol Immunol Infect. 2013;46:202\u20139.","journal-title":"J Microbiol Immunol Infect"},{"key":"749_CR19","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0924-8579(12)70008-0","volume":"40","author":"PL Lu","year":"2012","unstructured":"Lu PL, et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009\u20132010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents. 2012;40:S37\u201343.","journal-title":"Int J Antimicrob Agents"},{"key":"749_CR20","first-page":"670","volume":"58","author":"J Hanley","year":"2009","unstructured":"Hanley J, Branford I, Gugnan HC, Wilkinson C. U. T. urinary bacterial pathognes in St. Kitts.pdf. West Indies Med J. 2009;58:670.","journal-title":"West Indies Med J"},{"key":"749_CR21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3855\/jidc.196","volume":"2","author":"A Kothari","year":"2008","unstructured":"Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries. 2008;2:354\u20138.","journal-title":"J Infect Dev Ctries"},{"key":"749_CR22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1756-0500-5-219","volume":"5","author":"J-FTK Akoachere","year":"2012","unstructured":"Akoachere J-FTK, Yvonne S, Akum NH, Seraphine EN. Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns. BMC Res Notes. 2012;5:219.","journal-title":"BMC Res Notes"},{"key":"749_CR23","unstructured":"Fosse-Edorh S. Journ\u00e9e modiale du diab\u00e8te. Beh. 2014;30\u201331:491\u2013529."},{"key":"749_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mda.2003.8","volume":"49","author":"A Ronald","year":"2003","unstructured":"Ronald A. The etiology of urinary tract infection: Traditional and emerging pathogens. Dis Mon. 2003;49:71\u201382.","journal-title":"Dis Mon"},{"key":"749_CR25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1086\/428353","volume":"40","author":"R Raz","year":"2005","unstructured":"Raz R, Colodner R, Kunin CM. Who are you - Staphylococcus saprophyticus? Clin Infect Dis. 2005;40:896\u20138.","journal-title":"Clin Infect Dis"},{"key":"749_CR26","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/AAC.06060-11","volume":"56","author":"GV Sanchez","year":"2012","unstructured":"Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother. 2012;56:2181\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"749_CR27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","volume":"34","author":"GC Schito","year":"2009","unstructured":"Schito GC, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34:407\u201313.","journal-title":"Int J Antimicrob Agents"},{"key":"749_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkl466","volume":"59","author":"F Randrianirina","year":"2007","unstructured":"Randrianirina F, et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother. 2007;59:309\u201312.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajic.2012.09.015","volume":"41","author":"KL Ma","year":"2013","unstructured":"Ma KL, Wang CX. Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: Results based on a retrospective study from a tertiary hospital. Am J Infect Control. 2013;41:601\u20136.","journal-title":"Am J Infect Control"},{"key":"749_CR30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jinf.2008.09.034","volume":"57","author":"KB Laupland","year":"2008","unstructured":"Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JDD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect. 2008;57:441\u20138.","journal-title":"J Infect"},{"key":"749_CR31","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/jac\/dkp108","volume":"63","author":"C Arpin","year":"2009","unstructured":"Arpin C, et al. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother. 2009;63:1205\u201314.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JDD Pitout","year":"2008","unstructured":"Pitout JDD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159\u201366.","journal-title":"Lancet Infect Dis"},{"key":"749_CR33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1086\/527386","volume":"46","author":"SP Smith","year":"2008","unstructured":"Smith SP, Manges AR, Riley LW. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Clin Infect Dis. 2008;46:689\u201395.","journal-title":"Clin Infect Dis"},{"key":"749_CR34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1469-0691.2012.03805.x","volume":"19","author":"S Breurec","year":"2013","unstructured":"Breurec S, et al. Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: Multiclonal population structure with two major international clonal groups, CG15 and CG258. Clin Microbiol Infect. 2013;19:349\u201355.","journal-title":"Clin Microbiol Infect"},{"key":"749_CR35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy KK, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597\u2013602.","journal-title":"Lancet Infect Dis"},{"key":"749_CR36","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.ijid.2015.03.002","volume":"34","author":"S Bastian","year":"2015","unstructured":"Bastian S, et al. First case of NDM-1 producing Klebsiella pneumoniae in Caribbean islands. Int J Infect Dis. 2015;34:e53\u20134.","journal-title":"Int J Infect Dis"},{"key":"749_CR37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jgar.2015.04.004","volume":"3","author":"S Breurec","year":"2015","unstructured":"Breurec S, et al. Emergence of OXA-48-producing Escherichia coli in the Caribbean islands. J Glob Antimicrob Resist. 2015;3:217\u20138.","journal-title":"J Glob Antimicrob Resist"},{"key":"749_CR38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1590\/S0074-02762006000700006","volume":"101","author":"SS Andrade","year":"2006","unstructured":"Andrade SS, et al. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: Time for local guidelines? Mem Inst Oswaldo Cruz. 2006;101:741\u20138.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"749_CR39","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jac\/dkq525","volume":"66","author":"N Vernaz","year":"2011","unstructured":"Vernaz N, et al. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother. 2011;66:928\u201335.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10096-014-2264-y","volume":"34","author":"O Grignon","year":"2014","unstructured":"Grignon O, et al. Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter? Eur J Clin Microbiol Infect Dis. 2014;34:571\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"749_CR41","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/jac\/dkh229","volume":"53","author":"ML Heginbothom","year":"2004","unstructured":"Heginbothom ML, et al. Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. J Antimicrob Chemother. 2004;53:1010\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jac\/dki158","volume":"56","author":"JA Dromigny","year":"2005","unstructured":"Dromigny JA, Nabeth P, Juergens-Behr A, Perrier-Gros-Claude JD. Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal. J Antimicrob Chemother. 2005;56:236\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR43","doi-asserted-by":"crossref","first-page":"976273","DOI":"10.1155\/2012\/976273","volume":"2012","author":"A Dalhoff","year":"2012","unstructured":"Dalhoff A. Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis. 2012;2012:976273.","journal-title":"Interdiscip Perspect Infect Dis"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-016-0749-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T04:59:10Z","timestamp":1656737950000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-016-0749-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,24]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1186\/s12866-016-0749-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,24]]},"article-number":"121"}}